Corrigendum to “Characterizing the Therapeutic Potential of a Potent BET Degrader in Merkel Cell Carcinoma” [Neoplasia, Volume 21, Issue 3 (2019) 322–330]
Jae Eun Choi , Monique E. Verhaegen , Sahr Yazdani , Rohit Malik , Paul W. Harms , Doris Mangelberger , Jean Tien , Xuhong Cao , Yuping Wang , Marcin Cieślik , Jonathan Gurkan , Mishaal Yazdani , Xiaojun Jing , Kristin Juckette , Fengyun Su , Rui Wang , Bing Zhou , Ingrid J. Apel , Shaomeng Wang , Andrzej A. Dlugosz , Arul M. Chinnaiyan
{"title":"Corrigendum to “Characterizing the Therapeutic Potential of a Potent BET Degrader in Merkel Cell Carcinoma” [Neoplasia, Volume 21, Issue 3 (2019) 322–330]","authors":"Jae Eun Choi , Monique E. Verhaegen , Sahr Yazdani , Rohit Malik , Paul W. Harms , Doris Mangelberger , Jean Tien , Xuhong Cao , Yuping Wang , Marcin Cieślik , Jonathan Gurkan , Mishaal Yazdani , Xiaojun Jing , Kristin Juckette , Fengyun Su , Rui Wang , Bing Zhou , Ingrid J. Apel , Shaomeng Wang , Andrzej A. Dlugosz , Arul M. Chinnaiyan","doi":"10.1016/j.neo.2024.100995","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":18917,"journal":{"name":"Neoplasia","volume":null,"pages":null},"PeriodicalIF":4.8000,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1476558624000368/pdfft?md5=156fcd581778b8314c14eba99ba0dade&pid=1-s2.0-S1476558624000368-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neoplasia","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1476558624000368","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
期刊介绍:
Neoplasia publishes the results of novel investigations in all areas of oncology research. The title Neoplasia was chosen to convey the journal’s breadth, which encompasses the traditional disciplines of cancer research as well as emerging fields and interdisciplinary investigations. Neoplasia is interested in studies describing new molecular and genetic findings relating to the neoplastic phenotype and in laboratory and clinical studies demonstrating creative applications of advances in the basic sciences to risk assessment, prognostic indications, detection, diagnosis, and treatment. In addition to regular Research Reports, Neoplasia also publishes Reviews and Meeting Reports. Neoplasia is committed to ensuring a thorough, fair, and rapid review and publication schedule to further its mission of serving both the scientific and clinical communities by disseminating important data and ideas in cancer research.